VIVEX Biologics
PrivateLast Round
Debt
Apr 6, 2017
Total Funding Raised
$23.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
VIVEX Biologics is a regenerative medicine company that develops and delivers innovative allografts for orthopedic, spine, wound care, and pain management applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VIVEX Biologics Comparables
Compare VIVEX Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| StimLabs | 87% | |
| Skye Biologics Holdings | 86% | |
| Pinnacle Transplant Technologies | 84% |
VIVEX Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 6, 2017 | ||||
| Series A | Jan 6, 2016 | ||||
| Private Equity | Sep 18, 2013 |
VIVEX Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JAM Capital Partners | Private Equity |
| Ellis Capital | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 40% MoM.
VIVEX Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VIVEX Biologics's valuation, stock price, and market status.
Is VIVEX Biologics a public or private company?
VIVEX Biologics is a private company.
What is the current stock price of VIVEX Biologics?
VIVEX Biologics is a private company with no public stock price. No recent secondary market data is available.
How much is VIVEX Biologics worth (valuation)?
Valuation information for VIVEX Biologics is not publicly available.
Can I buy VIVEX Biologics stock?
VIVEX Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was VIVEX Biologics's last funding round?
VIVEX Biologics's most recent funding round was Debt on April 6, 2017.
Who are the main investors in VIVEX Biologics?
Key investors in VIVEX Biologics include JAM Capital Partners, Ellis Capital.
Will VIVEX Biologics IPO soon?
No public IPO plans have been announced for VIVEX Biologics.
How can I track VIVEX Biologics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VIVEX Biologics's secondary market activity and sign up for updates.